Answers are grounded in this paper and cite their sources.
Evaluates the efficacy of PRP on pain and function in foot and ankle conditions, indicating variability in outcomes.
Platelet-rich plasma (PRP) has emerged as a regenerative treatment option for various foot and ankle pathologies, containing growth factors and anti-inflammatory proteins to promote tissue healing. The most consistent clinical evidence supports PRP use for plantar fasciitis and osteochondral lesions of the talus, with significant improvements in pain and function observed. In contrast, outcomes for Achilles tendon pathologies and ankle osteoarthritis are mixed, demonstrating heterogeneity in PRP preparation and implementation. Future high-quality, standardized studies are necessary to determine the efficacy, optimal protocols, and long-term outcomes of PRP in foot and ankle pathologies.
No takes yet. Share an insight, caveat, or question.
Rubin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: